Consistently, heterozygous TNFAIP3 depletion reversed the improved glucose metabolic abnormalities and insulin resistance resulting from GPSM1 deficiency, as revealed by glucose-tolerance tests and insulin-tolerance tests (Fig. 6g, h). The gene discussed is GPSM1; the disease is Insulin resistance.